Related Experiment Video

Updated: Apr 25, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.2K

[Pathogenic analysis of ventilator-associated pneumonia in the pediatric intensive care unit in high-altitude areas]

Yan-Liang Xia1, Mei Ge, Zhen Wang

  • 1Intensive Care Unit, Qinghai Provincial Women and Children's Hospital, Xining 810007, China. xyl_70@126.com.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|August 21, 2014
PubMed

Insights

Ventilator-associated pneumonia (VAP) in high-altitude pediatric intensive care units (PICUs) is often caused by drug-resistant Gram-negative bacteria, frequently leading to mixed infections. Understanding these pathogens is crucial for effective VAP prevention and treatment strategies.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pediatric Critical Care

Context:

  • Ventilator-associated pneumonia (VAP) poses a significant challenge in pediatric intensive care units (PICUs), particularly in high-altitude regions.
  • Limited data exists on the specific pathogens and their antimicrobial resistance patterns in this unique environment.

Purpose:

  • To identify the causative pathogens of VAP in a high-altitude PICU setting.
  • To determine the antimicrobial susceptibility profiles of these pathogens.
  • To provide a clinical evidence base for VAP management in high-altitude pediatric populations.

Summary:

  • A study of 94 children with VAP in a high-altitude PICU revealed that Gram-negative bacteria, primarily Klebsiella pneumoniae and Acinetobacter baumannii, were the predominant pathogens.
  • Mixed infections were common (77%), and a high prevalence of antimicrobial resistance was observed, with Gram-negative bacteria showing extensive resistance.
  • Pseudomonas aeruginosa exhibited extensive drug resistance, while Acinetobacter baumannii remained sensitive only to specific antibiotics like cefoperazone/sulbactam and imipenem. Methicillin-resistant Staphylococcus aureus was noted among Gram-positive isolates.

Impact:

  • Findings highlight the significant threat of multidrug-resistant Gram-negative bacteria in high-altitude pediatric VAP cases.
  • Results guide the rational selection of antimicrobial agents for VAP treatment in these specific geographic and clinical settings.
  • Informs the development of targeted VAP prevention and control measures in high-altitude PICUs.
Abstract

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.0K

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
20
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.5K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
78